Insights | Meet Life Sciences

Back

Back to resources

Displaying 1 - 10 of 198

Meet News
Meet Hosts Its First Roundtable Event in New York
On Friday 26th of September, Meet Life Sciences hosted its first executi...

By Rosie Barden October 27th, 2025
Life Sciences News
AstraZeneca and Daiichi Sankyo’s Remarkable Progress in Breast Cancer Immunotherapies
October is breast cancer awareness month, a time to support and make a difference ...

By Rosie Barden October 23rd, 2025
Meet People
Talent Spotlight: Jack’s Journey at Meet Life Sciences
Jack Blackton is a division manager at our London HQ, who’s been here for just ove...

By Rosie Barden October 22nd, 2025
Life Sciences News
Science Fiction Turned Reality: Recent AI and Med Tech Developments Transforming Patient Outcomes
Since the AI boom took place several years ago, artificial intelligence has&n...

By Rosie Barden October 7th, 2025
Resources, Recruitment
Women in Leadership 2025 White Paper
Since publishing our first white paper on this topic two years ago, we've decided to revisit...

By Rosie Barden September 26th, 2025
Resources
We've Had Reports of People Impersonating Us
We’ve had reports of people impersonating our employees by using a variation of their email ...

By Rosie Barden September 22nd, 2025
Industry Events
Meet Life Sciences Sponsors Leap TA: Life Sciences 2025
We are delighted to be sponsoring Leap TA: Life Sciences 2025, the only ...

By Rosie Barden September 22nd, 2025
Life Sciences News
Precision Neuroscience: An Innovative Company Delivering Brain-Computer Interface (BCI) Technology
Neurotechnology is a fascinating field that aims to unlock and decipher the c...

By Rosie Barden September 9th, 2025
Meet People
The Meet Passport: Chris’ Trip to New York
Chris Warman heads up our Delivery team in the London office. When he hit four years of tenu...

By Rosie Barden August 26th, 2025
Life Sciences News
Cycle Pharmaceuticals: The Company Behind the First FDA-Approved Drug for Alkaptonuria
Alkaptonuria (AKU) is an ultra-rare condition that’s characterized...

By Rosie Barden August 5th, 2025